(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDSIGHT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MEDSIGHT

ST13

US500000086472835

Class

9

Filing

86472835

Registration

4875741

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

07/08/2025

Trademark type

Combined

Nice classes

9

Filing date

12/05/2014

Registration date

12/22/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/16/2025

Last transaction

07/08/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/08/2011

First use in commerce

12/05/2014

Drawing code

5

Owner type

99

Owner location

Nanshan, Shenzhen, CN

Examiner

NOVAKOVIC, MIROSLAV

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of stylized word of "medsight".

Holders and representatives

Holders

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

Representatives

Timothy T. Wang Ni Wang & Massand, PLLC

Technical classification

Nice Classes

Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Computer softwarean application allowing transmitting and viewing of images and data from a medical ultrasound apparatus to portable smart devices; Downloadable software applications for transmitting and viewing images and data from a medical ultrasound apparatus to portable smart devices

Publications

History of USPTO decisions and trademark events.

36 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/16/2025

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/16/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/16/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/16/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

01/09/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/22/2024

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

11/06/2021

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

11/06/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/06/2021

ES8R

TEAS SECTION 8 RECEIVED

06/25/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/22/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

12/22/2015

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/20/2015

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/19/2015

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/09/2015

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/09/2015

IUAF

USE AMENDMENT FILED

08/27/2015

EISU

TEAS STATEMENT OF USE RECEIVED

08/27/2015

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/25/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/30/2015

PUBO

PUBLISHED FOR OPPOSITION

06/30/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/10/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/28/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/27/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/01/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/01/2015

ALIE

ASSIGNED TO LIE

04/23/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/22/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/06/2015

GNRT

NON-FINAL ACTION E-MAILED

04/06/2015

CNRT

NON-FINAL ACTION WRITTEN

04/06/2015

DOCK

ASSIGNED TO EXAMINER

03/20/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/04/2015

MPMK

NOTICE OF PSEUDO MARK E-MAILED

12/12/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/11/2014

NWAP

NEW APPLICATION ENTERED

12/09/2014

Continuous trademark protection

Get notified about every new filing that threatens MEDSIGHT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.